Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Keep Its Positive Trend Going?

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Keep Its Positive Trend Going?

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Keep Its Positive Trend Going?

Can Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Continue Its Bullish Trend?

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has seen its share price leap +10.32% higher in the last 30-day period, but can it continue this positive trend? In calendar 2017 alone, the company’s stock has tumbled +16.81% higher. In the past 12 months, Rigel Pharmaceuticals, Inc. has risen +15.83%. The stock’s 52-week range is $1.94 to $ 4.38, and its three-month range has been $2.27 to $3.48.

At the moment, the company has 128.32M shares outstanding – bringing its market capitalization to $356.73M.

The stock’s 5-day moving average is currently $2.60, which is -6.47% below its most recent closing price of $2.78. The company’s 50-day moving average is $2.70, or -2.88% below the stock’s latest closing price, and its 100-day moving average is $2.68 – just -3.6% below its most recent closing price.

What is Wall Street saying?

The company’s stock is currently holding an average analyst rating of Strong Buy, according to the ratings of 4 Wall Street analysts. Of that group, no analysts rated Rigel Pharmaceuticals, Inc. as a Moderate Buy, 0 analysts rated it as a Hold, and no analysts rated it as a Strong Sell.

The company’s average rating has changed in recent months. Three months ago, 5 analysts weighed in on the stock – with 5 analysts rating it as a Strong Buy, no analyst rating it as a Moderate Buy, 0 analysts giving it a Hold, and no final analyst giving it a Strong Sell.

Diving Into Rigel Pharmaceuticals, Inc.’s Financials

Checking out a company’s Return on Assets (ROA) is useful in that it allows us to assess how well it is turning a profit in relation to its total assets. At the moment, Rigel Pharmaceuticals, Inc.’s ROA is -73.00%. The larger a company’s ROA, the better it is at generating income using its available assets.

Looking at a company’s gross margin shows us how much of its total sales revenue is not used on the cost of goods sold (COGS). In other words, gross margin shows the percentage of revenue retained when we exclude how much was spent on producing the sold goods.

We can also check out Rigel Pharmaceuticals, Inc.’s profit margin to see how it has been performing recently. We get a company’s profit margin when we divide its net income by its net sales.

Rigel Pharmaceuticals, Inc.’s operating margin is unknown. A company’s operating margin gives us insight into its operating efficiency and pricing strategy, by removing both depreciation and operating costs from net sales.

Risk Warning: Investing in digital currencies, stocks, shares and other securities, commodities, currencies and other derivative investment products (e.g. contracts for difference (“CFDs”) is speculative and carries a high level of risk. Each investment is unique and involves unique risks.

CFDs and other derivatives are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how an investment works and whether you can afford to take the high risk of losing your money.

Cryptocurrencies can fluctuate widely in prices and are, therefore, not appropriate for all investors. Trading cryptocurrencies is not supervised by any EU regulatory framework. Past performance does not guarantee future results. Any trading history presented is less than 5 years old unless otherwise stated and may not suffice as a basis for investment decisions. Your capital is at risk.

When trading in stocks your capital is at risk.

Past performance is not an indication of future results. Trading history presented is less than 5 years old unless otherwise stated and may not suffice as a basis for investment decisions. Prices may go down as well as up, prices can fluctuate widely, you may be exposed to currency exchange rate fluctuations and you may lose all of or more than the amount you invest. Investing is not suitable for everyone; ensure that you have fully understood the risks and legalities involved. If you are unsure, seek independent financial, legal, tax and/or accounting advice. This website does not provide investment, financial, legal, tax or accounting advice. Some links are affiliate links. For more information please read our full risk warning and disclaimer.